SEARCH

SEARCH BY CITATION

References

  • 1
    Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713723.
  • 2
    Racusen LC, Halloran PF, Solez K. Banff 2003 meeting report: New diagnostic insights and standards. Am J Transplant 2004; 4: 15621566.
  • 3
    Solez K, Colvin RB, Racusen LC et al. Banff '05 meeting report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (‘CAN’). Am J Transplant 2007; 7: 518526.
  • 4
    Billingham ME, Cary NRB, Hammond ME et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart rejection study group. J Heart Transplant 1990; 9: 587593.
  • 5
    Solez K, Axelsen RA, Benediktsson H et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411422.
  • 6
    Marcussen N, Lai R, Olsen TS, Solez K. Morphometric and immunohistochemical investigation of renal biopsies from patients with transplant ATN, native ATN, or acute graft rejection. Transplant Proc 1996; 28: 470476.
  • 7
    Dammin GJ. The kidney as a homograft and its host. Med Bull (Ann Arbor) 1960; 26: 278283.
  • 8
    Solez K, Racusen L, Rayner D, Olsen S, Halloran P. The Banff schema four years later. Transplant Proc 1996; 28: 450452.
  • 9
    Rush D, Nickerson P, Gough J et al. Beneficial effects of treatment of early subclinical rejection: A randomized study. J Am Soc Nephrol 1998; 9: 21292134.
  • 10
    Colvin RB, Cohen AH, Saiontz C et al. Evaluation of pathologic criteria for acute renal allograft rejection: Reproducibility, sensitivity, and clinical correlation. J Am Soc Nephrol 1997; 8: 19301941.
  • 11
    Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria – an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708714.
  • 12
    Salomon DR. Protocol biopsies should be part of the routine management of kidney transplant recipients. Con. Am J Kidney Dis 2002; 40: 674677.
  • 13
    Rush D. Protocol biopsies should be part of the routine management of kidney transplant recipients. Pro. Am J Kidney Dis 2002; 40: 671673.
  • 14
    Mueller A, Schnuelle P, Waldherr R, Van Der Woude FJ. Impact of the Banff '97 classification for histological diagnosis of rejection on clinical outcome and renal function parameters after kidney transplantation. Transplant 2000; 69: 11231127.
  • 15
    Furness PN, Taub N. International variation in the interpretation of renal transplant biopsies: Report of the CERTPAP Project. Kidney Int 2001; 60: 19982012.
  • 16
    Haas M, Kraus ES, Samaniego-Picota M, Racusen LC, Ni W, Eustace JA. Acute renal allograft rejection with intimal arteritis: Histologic predictors of response to therapy and graft survival. Kidney Int 2002; 61: 15161526.
  • 17
    Jabs WJ, Sedlmeyer A, Ramassar V et al. Heterogeneity in the evolution and mechanisms of the lesions of kidney allograft rejection in mice. Am J Transplant 2003; 3: 15011509.
  • 18
    Halloran PF, Urmson J, Ramassar V et al. Lesions of T-cell-mediated kidney allograft rejection in mice do not require perforin or granzymes A and B. Am J Transplant 2004; 4: 705712.
  • 19
    Einecke G, Fairhead T, Hidalgo LG et al. Tubulitis and epithelial cell alterations in mouse kidney transplant rejection are independent of CD103, perforin or granzymes A/B. Am J Transplant 2006; 6: 21092120.
  • 20
    Einecke G, Broderick G, Sis B, Halloran PF. Early loss of renal transcripts in kidney allografts: Relationship to the development of histologic lesions and alloimmune effector mechanisms. Am J Transplant 2007; 7: 11211130.
  • 21
    Solez K, Benediktsson H, Cavallo T et al. Report of the third Banff conference on allograft pathology (July 20–24, 1995) on classification and lesion scoring in renal allograft pathology. Transplant Proc 1996; 28: 441444.
  • 22
    Marcussen N, Olsen TS, Benediktsson H, Racusen L, Solez K. Reproducibility of the Banff classification of renal allograft pathology. Inter- and intraobserver variation. Transplant 1995; 60: 10831089.
  • 23
    Furness PN, Taub N, Assmann KJ et al. International variation in histologic grading is large, and persistent feedback does not improve reproducibility. Am J Surg Pathol 2003; 27: 805810.
  • 24
    Solez K, Hansen HE, Kornerup HJ et al. Clinical validation and reproducibility of the Banff schema for renal allograft pathology. Transplant Proc 1995; 27: 10091011.
  • 25
    Gough J, Rush D, Jeffery J et al. Reproducibility of the Banff schema in reporting protocol biopsies of stable renal allografts. Nephrol Dial Transplant 2002; 17: 10811084.
  • 26
    Veronese FV, Manfro RC, Roman FR et al. Reproducibility of the Banff classification in subclinical kidney transplant rejection. Clin Transplant 2005; 19: 518521.
  • 27
    Saad R, Gritsch HA, Shapiro R et al. Clinical significance of renal allograft biopsies with “borderline changes,” as defined in the Banff Schema. Transplant 1997; 64: 992995.
  • 28
    Meehan SM, Siegel CT, Aronson AJ et al. The relationship of untreated borderline infiltrates by the Banff criteria to acute rejection in renal allograft biopsies. J Am Soc Nephrol 1999; 10: 18061814.
  • 29
    Schweitzer EJ, Drachenberg CB, Anderson L et al. Significance of the Banff borderline biopsy. Am J Kidney Dis 1996; 28: 585588.
  • 30
    Einecke G, Melk A, Ramassar V et al. Expression of CTL associated transcripts precedes the development of tubulitis in T-cell mediated kidney graft rejection. Am J Transplant 2005; 5: 18271836.
  • 31
    Racusen LC. Molecular techniques in transplantation. Transplant Proc 2004; 36: 731732.
  • 32
    Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J. Lymphoma classification–from controversy to consensus: The R.E.A.L. and WHO classification of lymphoid neoplasms. Ann Oncol 2000; 11(Suppl 1): 310.
  • 33
    Mengel M, Gwinner W, Schwarz A et al. Infiltrates in protocol biopsies from renal allografts. Am J Transplant 2007; 7: 356365.